Structured grief counseling reduces grief and improves quality of life for family caregivers of ad

Background

This randomized controlled trial assessed whether a structured grief counseling program delivered to family caregivers of patients with advanced cancer, beginning in the terminal phase and continuing through early bereavement, affects grief responses and related psychological and health outcomes. The authors framed the work to inform bereavement care in oncology and hospice settings.

Methods

The study was conducted from October 2024 to November 2025. Family caregivers of patients with advanced cancer were randomized to either a structured grief counseling intervention (intervention group, n = 55) or provision of psychological materials only (control group, n = 56).

Counseling began before the patient's death and continued for three months after death. Outcomes were assessed at enrollment, at the end of the intervention, and at 1 month and 3 months after the death. Statistical analyses used linear mixed-effects models to estimate group differences over time.

The abstract lists the primary and secondary outcome domains measured but does not specify the counseling session frequency, duration, individual versus group format, or the manualized content in the abstract.

Outcomes and measurement

Measured constructs and instruments reported in the abstract include:

• Grief, assessed with the Anticipatory Grief Scale (reported in group comparisons over time).
• Post-traumatic growth, measured with the Post-traumatic Growth Inventory.
• Health-related quality of life, measured with the Short-Form 36 Health Survey.
• Bereavement guilt, measured with the Bereavement Guilt Scale.
• Anxiety and depression, measured with the Self-Rating Anxiety Scale and the Self-Rating Depression Scale, respectively.

Assessments occurred at enrollment, at the intervention endpoint, and at 1 and 3 months after the patient's death, allowing evaluation of effects across the transition from terminal caregiving into early bereavement.

Results

Key trial findings reported in the abstract are:

• The intervention group experienced significantly lower Anticipatory Grief Scale scores over time compared with control (estimate = -9.31, P < 0.001), indicating a reduction in measured grief.

• Participants who received structured grief counseling had higher Post-traumatic Growth Inventory scores over time (estimate = 6.02, P < 0.001), indicating greater post-traumatic growth than controls.

• Health-related quality of life as measured by the Short-Form 36 Health Survey was higher in the intervention group over time (estimate = 5.97, P < 0.001).

• Between-group differences were not statistically significant for Bereavement Guilt Scale scores, Self-Rating Anxiety Scale scores, and Self-Rating Depression Scale scores.

These results indicate selective benefits of the intervention: significant improvement in grief, psychological growth, and overall health-related quality of life, but no detectable effect on guilt, anxiety, or depression within the follow-up reported in the abstract.

Interpretation and conclusions

The authors conclude that providing a standardized, family-centered structured grief counseling program from the patient's terminal phase through early bereavement effectively improves caregiver grief status, promotes post-traumatic growth, and enhances health-related quality of life. They interpret these findings as supporting the integration of standardized bereavement support systems into oncology and hospice services.

Implications for oncology and hospice bereavement care

• The trial provides randomized evidence favoring delivery of structured, time-limited counseling that spans the terminal caregiving period and the immediate months after death.
• Measured benefits include reduced anticipatory grief and improvements in post-traumatic growth and quality of life—domains relevant to family-centered palliative care.
• The absence of significant differences in bereavement guilt, anxiety, and depression suggests the intervention may be most effective for grief processing and broader well-being, while additional or alternative approaches may be needed to target guilt and clinical anxiety or depression.

Study details and information not reported in the abstract

• The abstract does not report the detailed content of the counseling protocol (session structure, therapeutic techniques, number and length of sessions, provider qualifications, or fidelity checks).
• The abstract does not present demographic or baseline characteristic tables in detail, so the reader cannot assess balance across arms or generalizability from the abstract alone.
• Information on adverse events, retention rates, missing data, and sensitivity analyses are not reported in the abstract.
• Full-text review would be required to evaluate methodological details such as randomization sequence generation, allocation concealment, blinding (if any), and trial registration beyond the PMID and DOI supplied in the record.

Bottom line

In this randomized trial of caregivers of patients with advanced cancer (n = 111 randomized), a structured grief counseling program spanning the terminal phase through three months post-death produced significant reductions in measured grief and significant increases in post-traumatic growth and health-related quality of life, while not significantly affecting bereavement guilt, anxiety, or depression according to the abstract. The authors recommend integrating standardized, family-centered bereavement support into oncology and hospice care; further appraisal of the full text is necessary to examine intervention components, fidelity, and applicability across settings.